Page last updated: 2024-10-30

mecamylamine and Breast Neoplasms

mecamylamine has been researched along with Breast Neoplasms in 1 studies

Mecamylamine: A nicotinic antagonist that is well absorbed from the gastrointestinal tract and crosses the blood-brain barrier. Mecamylamine has been used as a ganglionic blocker in treating hypertension, but, like most ganglionic blockers, is more often used now as a research tool.

Breast Neoplasms: Tumors or cancer of the human BREAST.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Jimenez, T1
Friedman, T1
Vadgama, J1
Singh, V1
Tucker, A1
Collazo, J1
Sinha, S1
Hikim, AS1
Singh, R1
Pervin, S1

Other Studies

1 other study available for mecamylamine and Breast Neoplasms

ArticleYear
Nicotine Synergizes with High-Fat Diet to Induce an Anti-Inflammatory Microenvironment to Promote Breast Tumor Growth.
    Mediators of inflammation, 2020, Volume: 2020

    Topics: Animal Feed; Animals; Anti-Inflammatory Agents; Breast Neoplasms; Cell Line, Tumor; Cell Proliferati

2020